Drugs / Hexavalent (DTwP-HepB-IPV-Hib) Vaccine Containing Full Dose IPV
Hexavalent (DTwP-HepB-IPV-Hib) Vaccine Containing Full Dose IPV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT06413121 Comparator | May 2024 → Mar 2025 | acute hepatitis B virus infection, diphtheria, pertussis, poliomyelitis | Serum Institute of India Pvt. Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hexavalent (DTwP-HepB-IPV-Hib) Vaccine Containing Full Dose IPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06413121 ↗ |
| Modality | Vaccine | “SIIPL HEXASIIL® vaccine” NCT06413121 ↗ |